David Lebowitz

Stock Analyst at Citi

(4.75)

# 652

Out of 4,692 analysts

2

Total ratings

59.9%

Success rate

14.2%

Average return

Main Sectors:

Top Industries:

Biotechnology Drug Manufacturers - Specialty & Generic Health Information Services

Stocks Rated by David Lebowitz

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	IONS Ionis Pharmaceuticals	Maintained: Hold	$60	$61.05	-1.72%	1	Aug 31, 2026
	ALNY Alnylam Pharmaceuticals	Maintained: Buy	$318	$237.10	+34.12%	1	Aug 31, 2026

Ionis Pharmaceuticals

Aug 31, 2026

Maintained: Hold

Price Target: $60

Current: $61.05

Upside: -1.72%

Alnylam Pharmaceuticals

Aug 31, 2026

Maintained: Buy

Price Target: $318

Current: $237.10

Upside: +34.12%